AF
SQZ

Amalgamated Financial’s SQZ Biotechnologies Company SQZ Stock Holding History

Amalgamated Financial’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$13K Buy
+2,753
New +$17.5K ﹤0.01% 2855

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's SQZ Position: Q1 2022 in Review

Amalgamated Financial opened a new position in SQZ Biotechnologies Company (SQZ) in Q1 2022: 2,753 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #2855 among its holdings.

53 funds tracked by Wall St. Rank hold SQZ as of Q1 2022.

  • Amalgamated Financial held 2,753 shares of SQZ Biotechnologies Company worth $13K as of Q1 2022.
  • SQZ Biotechnologies Company was a new Amalgamated Financial position in Q1 2022.
  • SQZ Biotechnologies Company made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2855 holding.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.